New Delhi: The Indian Pharmaceutical Alliance (IPA) announced on Friday that the recent decision by US President Donald Trump to implement a 100% import tariff on pharmaceutical products starting ...

NEW DELHI, Sept 5 (Reuters) - The Netherlands is aiming to increase imports of Indian generic drugs into the country, as it looks to diversify its portfolio and avoid supply constraints, Dutch ...

On Monday, Indian and EU officials will try to salvage a wide-ranging trade agreement. Talks stalled last fall when India walked out due to EU bans on hundreds of Indian-approved medicines. EU ...

The proposed 100% tariff on patented drugs in the United States is expected to significantly impact the global pharmaceutical sector. This move could increase the prices of patented medicines, ...

Indian pharmaceutical companies are positioned to capture up to $5 billion of a massive $142 billion patent expiry wave between 2026 and 2030, driven by a structural shift toward complex biologics.